These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 19220072)
61. Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy. Moran NF; Poole K; Bell G; Solomon J; Kendall S; McCarthy M; McCormick D; Nashef L; Sander J; Shorvon SD Seizure; 2004 Sep; 13(6):425-33. PubMed ID: 15276147 [TBL] [Abstract][Full Text] [Related]
63. Economic impact of epilepsy and the cost of nonadherence to antiepileptic drugs in older Medicare beneficiaries. Ip Q; Malone DC; Chong J; Harris RB; Labiner DM Epilepsy Behav; 2018 Mar; 80():208-214. PubMed ID: 29414554 [TBL] [Abstract][Full Text] [Related]
64. Epilepsy in the elderly: the use of tiagabine. Pedersen B Epilepsia; 2001; 42 Suppl 3():52-4. PubMed ID: 11520325 [TBL] [Abstract][Full Text] [Related]
68. Management of seizures in the elderly. Rowan AJ Pharmacotherapy; 2000 Aug; 20(8 Pt 2):178S-184S. PubMed ID: 10937817 [TBL] [Abstract][Full Text] [Related]
69. Monotherapy in adults and elderly persons. Faught E Neurology; 2007 Dec; 69(24 Suppl 3):S3-9. PubMed ID: 18071156 [TBL] [Abstract][Full Text] [Related]
70. Medical management of epilepsy in adults. Mattson RH Neurology; 1998 Nov; 51(5 Suppl 4):S15-20. PubMed ID: 9818919 [TBL] [Abstract][Full Text] [Related]
71. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy. Arif H; Buchsbaum R; Pierro J; Whalen M; Sims J; Resor SR; Bazil CW; Hirsch LJ Arch Neurol; 2010 Apr; 67(4):408-15. PubMed ID: 20385905 [TBL] [Abstract][Full Text] [Related]
72. Co-morbidity and clinically significant interactions between antiepileptic drugs and other drugs in elderly patients with newly diagnosed epilepsy. Bruun E; Virta LJ; Kälviäinen R; Keränen T Epilepsy Behav; 2017 Aug; 73():71-76. PubMed ID: 28622547 [TBL] [Abstract][Full Text] [Related]
73. New anti-seizure medication for elderly epileptic patients. Watkins L; O'Dwyer M; Shankar R Expert Opin Pharmacother; 2019 Sep; 20(13):1601-1608. PubMed ID: 31112437 [No Abstract] [Full Text] [Related]
74. Anticonvulsants: choices and costs. Based on a presentation by Nina Graves, PharmD, FCCP. Am J Manag Care; 1998 Sep; 4(9 Suppl):S463-7; discussion S468-74. PubMed ID: 10185985 [TBL] [Abstract][Full Text] [Related]
75. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis. Chisholm D; Epilepsia; 2005 May; 46(5):751-9. PubMed ID: 15857443 [TBL] [Abstract][Full Text] [Related]
76. Economic burden associated with the use of generic antiepileptic drugs in the United States. Helmers SL; Paradis PE; Manjunath R; Duh MS; Lafeuille MH; Latrémouille-Viau D; Lefebvre P; Labiner DM Epilepsy Behav; 2010 Aug; 18(4):437-44. PubMed ID: 20580619 [TBL] [Abstract][Full Text] [Related]
77. Relationship of antiepileptic drugs to generic brittleness in patients with epilepsy. Das S; Jiang X; Jiang W; Ting TY; Polli JE Epilepsy Behav; 2020 Apr; 105():106936. PubMed ID: 32092462 [TBL] [Abstract][Full Text] [Related]
78. Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. Alacqua M; Trifirò G; Spina E; Moretti S; Tari DU; Bramanti P; Caputi AP; Arcoraci V Epilepsy Res; 2009 Jul; 85(1):107-13. PubMed ID: 19345564 [TBL] [Abstract][Full Text] [Related]
79. Epilepsy in the elderly: some clinical and pharmacotherapeutic aspects. Krämer G Epilepsia; 2001; 42 Suppl 3():55-9. PubMed ID: 11520326 [TBL] [Abstract][Full Text] [Related]
80. Assessment of tolerability in elderly patients: changing to lamotrigine therapy. Evans BK; Kustra RP; Hammer AE Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]